The benefit of thrombus aspiration during percutaneous coronary intervention in patients with acute myocardial infarction (AMI) is well established; however, the optimal management strategy for patients with a large thrombus burden after repeated thrombectomy (i.e., "failed" thrombectomy) is unknown. Here, we report the case of a 67-year-old male with polycythemia vera who was treated with intracoronary thrombolytic therapy in combination with mechanical thrombectomy. Repeated aspiration thrombectomy did little to reduce the coronary thrombus burden; thus, intracoronary urokinase infusions were applied to the thrombus-containing lesion. Repeat coronary angiography 4 days later revealed markedly improved antegrade flow in the infarct-related artery, and successful revascularization was performed. This case demonstrates the potential utility of intracoronary thrombolytic therapy for select AMI patients with a large thrombus burden who are in a hypercoagulable state. (Korean J Med 2014;87:728-732) 
INTRODUCTION
In patients with acute myocardial infarction (AMI), intracoronary thrombus is present in high proportion and associated with adverse outcome [1] . As is well known, culprit lesion of AMI is usually a composite of atherosclerotic plaque and thrombus [2] . Mechanical thrombectomy of infarct related artery (IRA) can dramatically reduce thrombus burden, which facilitates the procedure through better visualization of the culprit lesion [3] .
The results of intracoronary thrombolytic therapy in dissolving thrombus, however, have been discouraging and currently rarely used [4] . We report the patients with polycythemia vera (PV) who presented with AMI with large thrombus burden. The treatment option for management of intracoronary thrombi in PV patients will be discussed.
CASE REPORT
A 67-year-old man presented to emergency room (ER) with squeezing chest discomfort for 5 days. He had been in stable condition for hypertension and PV with antihypertensive medication and occasional phlebotomy, when chest discomfort devel- In the 1980s, before the era of PCI for AMI, there was considerable interest in the intracoronary delivery of thrombolytic agent. Angiographic resolution of intracoronary thrombi, however, has been variable and results have largely been discouraging [5] . However, several studies still support the effectiveness of intracoronary thrombolysis in selected case. Pre- [6] or post- [7] treatment of low dose intracoronary thrombolysis during PCI was reported to be beneficial for complex lesion of AMI [8] , especially with large thrombus without significant increase in bleeding. Delayed PCI after pharmacologic treatment was also reported to be successful in large amount of coronary thrombosis [9] .
There is no firm evidence base to guide the management of AMI in patients with PV. It is not known whether AMI in patients with PV is caused by a typical platelet-rich "white" thrombus on a disrupted plaque. Macrovascular thrombosis is largely due to the associated hyperviscosity. Therefore, it is possible that coronary occlusion may be due to fibrin-rich "red" thrombi.
Little is known about the management of coronary thrombosis in AMI patients with PV. In the present case, coronary flow of culprit vessel was significantly limited even after the repeated thrombus aspiration. Even though there is a concern which PV might causes an unpredictable bleeding diathesis that may potentially increase the risk of fibrinolytic therapy, repeated infusion of intracoronary thrombolytic agents improved the coronary antegrade flow of culprit vessels. This is the first case which demonstrates successful pharmaco-mechanical approach for revascularization of large thrombi-containing lesion in AMI patient with PV. This case shows that intracoronary thrombolysis deserves reconsideration as an adjunct to mechanical thrombus aspiration in selected patients, especially in patients with huge thrombus burden in hypercoagulable status.
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